Real-world data from first UK Omnipod 5 users: A single-centre observational study

Aisha Aslam¹, Alyson Chapman¹, Andrea Urwin¹, Sheetal Ohol¹, Sonia Thomas¹, Rebecca Gough¹, Lynne-Ann Findlow¹, Jonathan Lim¹, Jonathan Schofield^{1

2}, Lalantha Leelarathna^{1

3}, Hood Thabit^{1

2}

Affiliations

¹ Diabetes, Endocrinology and Metabolism Center, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK.
² Division of Diabetes, Endocrinology and Gastroenterology, University of Manchester, Manchester, UK.
³ Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.

Observational Study

Aisha Aslam et al. Diabetes Obes Metab. 2024 Aug.

. 2024 Aug;26(8):3462-3465.

doi: 10.1111/dom.15629. Epub 2024 May 2.

¹ Diabetes, Endocrinology and Metabolism Center, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK.
² Division of Diabetes, Endocrinology and Gastroenterology, University of Manchester, Manchester, UK.
³ Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.

No abstract available

References

1. Daneman D. Type 1 diabetes. Lancet. 2006;367(9513):847‐858.
1. National Diabetes Audit, Report 1‐Care Processes and Treatment Targets 2020–21, Underlying Data. https://digital.nhs.uk/data‐and‐information/publications/statistical/nat... 2021: NHS Digital. Accessed December 08, 2021.
1. Pickup JC. Diabetes: insulin pumps after injections and CGM in T1DM. Nat Rev Endocrinol. 2017;13(10):568‐569.
1. Subramanian S, Khan F, Hirsch IB. New advances in type 1 diabetes. BMJ. 2024;384:e075681.
1. National Institute for Health and Care Excellence. Hybrid Closed Loop Systems for Managing Blood Glucose Levels in Type 1 Diabetes. https://www.nice.org.uk/guidance/ta9432023